Predict your next investment

HEALTHCARE | Biotechnology

See what CB Insights has to offer

Stage

Seed | Alive

About WellSIM BioMedical Technologies

WellSIM BioMedical Technologies focuses on exploring the possibility and potential of exosomes with advanced micro- and nano-technologies.

WellSIM BioMedical Technologies Headquarter Location

2355 Paragon Dr Suite C

San Jose, California, 95131,

United States

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing WellSIM BioMedical Technologies

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

WellSIM BioMedical Technologies is included in 1 Expert Collection, including Nanobiotechnology.

N

Nanobiotechnology

704 items

These companies apply nanotechnology to clinical medicine. They research or develop highly specific, nanoscale interventions to aid in screening, diagnosis, and treatment of biological systems.

WellSIM BioMedical Technologies Patents

WellSIM BioMedical Technologies has filed 3 patents.

The 3 most popular patent topics include:

  • Diagrams
  • Diseases of pleura
  • Analytical chemistry
patents chart

Application Date

Grant Date

Title

Related Topics

Status

11/29/2018

9/1/2020

Diseases of pleura, Diagrams, Pneumonia, Cell biology, Laboratory equipment

Grant

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

Application Date

11/29/2018

00/00/0000

00/00/0000

Grant Date

9/1/2020

00/00/0000

00/00/0000

Title

Subscribe to see more

Subscribe to see more

Related Topics

Diseases of pleura, Diagrams, Pneumonia, Cell biology, Laboratory equipment

Subscribe to see more

Subscribe to see more

Status

Grant

Subscribe to see more

Subscribe to see more

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.